Renal Resistive Index: not only kidney Pierpaolo Di NicolòAntonio Granata Review article 16 August 2016 Pages: 359 - 366
Does significant renal ablation truly and invariably lead to hyperfiltration and progressive chronic kidney disease? Andrew WangRamin Sam Review article 13 October 2016 Pages: 367 - 374
Polyuria due to vasopressin V2 receptor antagonism is not associated with increased ureter diameter in ADPKD patients Niek F. CasteleijnA. Lianne MesschendorpAnna M. Leliveld Original article 23 June 2016 Pages: 375 - 382
Comparison of cystatin C- and creatinine-based estimated glomerular filtration rates for predicting all-cause mortality in Japanese patients with type 2 diabetes: the Fukuoka Diabetes Registry Hitoshi IdeMasanori IwaseTakanari Kitazono Original article 23 June 2016 Pages: 383 - 390
Coronary artery calcification scores improve contrast-induced nephropathy risk assessment in chronic kidney disease patients Naohiro OsugiSusumu SuzukiToyoaki Murohara Original article 23 June 2016 Pages: 391 - 397
High serum level of methylglyoxal-derived AGE, Nδ-(5-hydro-5-methyl-4-imidazolone-2-yl)-ornithine, independently relates to renal dysfunction Kenji ItoNoriyuki SakataHitoshi Nakashima Original article 25 June 2016 Pages: 398 - 406
A phase 1 study of the safety, tolerability, pharmacodynamics, and pharmacokinetics of tenapanor in healthy Japanese volunteers Susanne JohanssonDavid P. RosenbaumMaria Leonsson-Zachrisson Original article Open access 01 July 2016 Pages: 407 - 416
Effects of atorvastatin on renal function in patients with dyslipidemia and chronic kidney disease: assessment of clinical usefulness in CKD patients with atorvastatin (ASUCA) trial Genjiro KimuraMasato KasaharaKazuwa Nakao Original article Open access 08 July 2016 Pages: 417 - 424
Physical function at the time of dialysis initiation is associated with subsequent mortality Daijo InagumaAkihito TanakaHibiki Shinjo Original article 08 July 2016 Pages: 425 - 435
Dual antiplatelet and anticoagulant APAC prevents experimental ischemia–reperfusion-induced acute kidney injury Raimo TuuminenAnnukka JouppilaRiitta Lassila Original article 12 July 2016 Pages: 436 - 445
Risk factors for CKD progression in Japanese patients: findings from the Chronic Kidney Disease Japan Cohort (CKD-JAC) study Daijo InagumaEnyu ImaiFor The Chronic Kidney Disease Japan Cohort Study Group Original article Open access 13 July 2016 Pages: 446 - 456
Association of interactions between dietary salt consumption and hypertension-susceptibility genetic polymorphisms with blood pressure among Japanese male workers Takahiro ImaizumiMasahiko AndoSeiichi Matsuo Original article 01 August 2016 Pages: 457 - 464
The Fukuoka Kidney disease Registry (FKR) Study: design and methods Shigeru TanakaToshiharu NinomiyaFukuoka Kidney disease Registry (FKR) Study Collaboration Group Original article 23 June 2016 Pages: 465 - 473
Genetic and environmental influences on the associations between change in kidney function and changes in cardiometabolic factors in Koreans Yun-Mi SongJoohon SungKayoung Lee Original article 23 June 2016 Pages: 474 - 480
The use of vitamin D analogs is independently associated with the favorable renal prognosis in chronic kidney disease stages 4–5: the CKD-ROUTE study Yohei AraiEiichiro KandaShinichi Uchida Original article 25 June 2016 Pages: 481 - 487
Diuretics prescribing in chronic kidney disease patients: physician assessment versus bioimpedence spectroscopy Yusra Habib KhanAzmi SarriffTauqeer Hussain Mallhi Original article 11 July 2016 Pages: 488 - 496
Associations between serum uric acid levels and the incidence of nonfatal stroke: a nationwide community-based cohort study Keita KameiTsuneo KontaTsuyoshi Watanabe Original article 12 July 2016 Pages: 497 - 503
Association between medication adherence and clinical outcomes in patients with chronic kidney disease: a prospective cohort study Mayuree TangkiatkumjaiDawn-Marie WalkerHelen Boardman Original article 20 July 2016 Pages: 504 - 512
Dose–response efficacy and safety of PA21 in Japanese hemodialysis patients with hyperphosphatemia: a randomized, placebo-controlled, double-blind, Phase II study Fumihiko KoiwaAkira Terao Original article Open access 07 July 2016 Pages: 513 - 522
Erratum to: Dose–response efficacy and safety of PA21 in Japanese hemodialysis patients with hyperphosphatemia: a randomized, placebo-controlled, double-blind, Phase II study Fumihiko KoiwaAkira Terao Erratum 10 November 2016 Pages: 523 - 523
Quantification of autonomic nervous activity by heart rate variability and approximate entropy in high ultrafiltration rate during hemodialysis Yoshihiro TsujiNaoki SuzukiYuko Mizuno-Matsumoto Original article 01 August 2016 Pages: 524 - 530
Design and baseline characteristics of the LANDMARK study Hiroaki OgataMasafumi FukagawaOn behalf of the LANDMARK Study Group Original article Open access 12 July 2016 Pages: 531 - 537
Renal parenchymal invasion by metastatic breast cancer Dearbhla M. KellyGasim AhmedLiam F. Casserly Images in Nephrology 08 July 2016 Pages: 538 - 539